Join us at the EHA 2024 Congress as we discuss how single-cell multiomics helps you better understand multiple myeloma and other heme indications.

Single-Cell Multiomics Presentations at the EHA 2024 Congress

To gain real-world insights into how our customers are utilizing Mission Bio's technology and the Tapestri Platform, check out the scientific oral presentations and posters presented at the congress below.

If you'd like to schedule a one-on-one meeting with our team to learn more about Tapestri and our upcoming products, fill out the short form on the right.
 

ORAL PRESENTATIONS

Sunday, 16 June, 12:15 - 12:30 CEST, Hall Blanchard

PRESENTATION ID S337
A NOVEL SINGLE-CELL MEASURABLE RESIDUAL DISEASE (SCMRD) ASSAY FOR SIMULTANEOUS DNA MUTATION AND SURFACE IMMUNOPHENOTYPE PROFILING
Gema Fuerte (Spain)
 

POSTERS

Friday 14 June, 18:00 - 19:00 CEST , Hall 7

POSTER ID P1064
CLINICAL AND MOLECULAR CHARACTERISATION OF PATIENTS WITH LOW JAK2V617F ALLELE BURDEN: INSIGHTS FROM LONGITUDINAL FOLLOW-UP
Nieves Garcia-Gisbert Hospital del Mar Research Institute, Barcelona / Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom (Barcelona , Spain)

POSTER ID P1714
CO-EVOLUTION OF MITOCHONDRIAL AND SOMATIC NUCLEAR DNA MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Livius Penter Charité - Universitätsmedizin Berlin (Berlin, Germany)

POSTER ID P2309
ASSESSING THE EFFICIENCY OF WHOLE EXOME SEQUENCING AND SINGLE-CELL DNA SEQUENCING FOR INTRATUMOR HETEROGENEITY AND CLONAL EVOLUTION IN ACUTE MYELOID LEUKEMIA
Sadiksha Adhikari University of Helsinki (Helsinki, Finland)

POSTER ID P887
SINGLE CELL MULTI-OMIC CLONAL TRACKING IN MYELOMA IDENTIFIES SMM CLONES THAT PROGRESS TO MM AND LOW FREQUENCY MM CLONES WITH RESISTANCE FEATURES ENABLING MORE PRECISE APPLICATION OF TARGETED THERAPIES
Todd Druley Mission Bio, Inc (United States of America)

 

Would you like to meet with us?